ARCHIVES

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

This article is from The Cancer Letter archive.

Vol. 23 No. 37 | September 26, 1997

Download PDF Visit The Full Archive

Related Articles

FDA Committee IK IL-2/LAK For Modified Group C

May 1, 1987

Senate Confirms McClellan For FDA

October 25, 2002

Eight Practicing Physicians On Board are Enough, Need Some Scientists Now, DeVita Says

December 9, 1983

In Brief : Patricia LoRusso Named Associate Director Of Innovative Medicine at Yale Cancer Center

June 20, 2014

National Cancer Policy Board will end in 2005, NCI to support a cancer forum at IOM.

November 5, 2004

Freireich, Moertel Matched Up Again

February 20, 1981